Doβ adrenergic agents directly stimulate gastrin secretion?
نویسندگان
چکیده
منابع مشابه
Pharmacological agents that directly modulate insulin secretion.
Blood glucose levels are sensed and controlled by the release of hormones from the islets of Langerhans in the pancreas. The beta-cell, the insulin-secreting cell in the islet, can detect subtle increases in circulating glucose levels and a cascade of molecular events spanning the initial depolarization of the beta-cell membrane culminates in exocytosis and optimal insulin secretion. Here we re...
متن کاملGastrin responses in patients with adrenergic insufficiency.
High basal gastrin levels in pure autonomic failure could result from peripheral vagus nerve involvement, whereas the increased response during hypoglycaemia may reflect adrenergic supersensitivity. A reduced gastrin increment in multiple system atrophy was found following insulin-hypoglycaemia and is consistent with decreased gastrin release secondary to diminished central sympathetic nervous ...
متن کاملNeonatal secretion of gastrin and glucagon.
Rogers, I. M., Davidson, D. C., Lawrence, J., Ardill, J., and Buchanan, K D. (1974). Archives of Disease in Childhood, 49, 796. Neonatal secretion of gastrin and glucagon. Plasma gastrin and glucagon levels were estimated in mothers after labour, and in their babies at birth and on the fourth day of life. The newly born baby appears to secrete gastrin independently and the plasma levels are hig...
متن کاملThe effects of Adrenergic agents on the dopaminergic-induced sniffing
There is evidence indicating that adrenoceptor mechanisms may influence some of the behaviors in rat. However the role of adrenoceptor agents on sniffing has not been identified. In the present study, the influence of adrenoceptor agents on sniffing induced by apomorphine and amphetamine has been investigated. Male Albino rats, weighing 150-250 g were used for all experiments. The behavior wa...
متن کاملNew agents that stimulate erythropoiesis.
Recombinant human erythropoietin (rhEpo) has proven to be remarkably safe and effective for treatment of anemias, primarily those secondary to renal disease and malignancy. Despite the worldwide use of rhEpo, concerns about its cost, the need for frequent parenteral administration, and the development of anti-Epo antibodies have prompted development of improved agents to stimulate erythropoiesi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Experientia
سال: 1978
ISSN: 0014-4754,1420-9071
DOI: 10.1007/bf01939688